Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CNTY-308 in B-cell ...
'Aging clock' computer model reveals aging processes in immune cells
Not only does our body change with age, but so does our immune system. A recent study led by the Center for Individualized Infection Medicine (CiiM) shows exactly how immune cells age and how ...
Multiple Sclerosis News Today7d
Epstein-Barr virus may drive MS by dysregulating certain immune cells
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...
Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg
Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the ...
Technology Networks5d
Cancer Immunotherapy Enhanced by Rewiring T-Cell Metabolism
Researchers from the VIB-KU Leuven Center for Cancer Biology, in collaboration with other scientists, have discovered a way ...
New thesis investigates the role of memory T cells in viral infections and their importance for long-term immunity
Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...
Knowridge Science Report20h
Scientists discover cause of inflammation in autoimmune diseases
Our immune system is constantly working to protect us from infections and injuries. One of its most powerful tools is ...
Morningstar2d
Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg
Pharmacodynamic data support proof of mechanism and show that MTX-101 is highly selective for regulatory CD8 T cells, and that engagement with MTX-101 results in CD8 Treg activation. Mozart plans ...